Skip to main content
AAN.com
Medical Hypothesis
September 10, 2018
Letter to the Editor

Idiopathic intracranial hypertension
The veno glymphatic connections

September 11, 2018 issue
91 (11) 515-522

Abstract

The recent discoveries of the glymphatic and lymphatic systems of the brain have helped advance our understanding of CSF physiology and may allow new insights in the understanding of idiopathic intracranial hypertension (IIH). The clinical and radiologic presentations of IIH appear to be related to congestion of the glymphatic system associated with an overflow of the lymphatic CSF outflow pathway. By revisiting the role of “vascular arachnoid granulations” in the brain, we hypothesize that an initial impairment of the transport of interstitial fluid from the glymphatic system to the venous blood of the dural sinuses may trigger the hydrodynamic cascade of IIH. Furthermore, we speculate that, similar to other water-exchange systems in the brain, a specific subtype of aquaporin is involved in this transport. This theory may eventually help to provide an underlying explanation for IIH and its associated conditions, since in most of them, the expression of several aquaporins is altered.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012;4:147ra111.
2.
Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015;523:337–341.
3.
Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 2015;212:991–999.
4.
Absinta M, Ha SK, Nair G, et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife 2017;6:e29738.
5.
Kress BT, Iliff JJ, Xia M, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014;76:845–861.
6.
Bezerra MLS, Ferreira A, de Oliveira-Souza R. Pseudotumor cerebri and glymphatic dysfunction. Front Neurol 2017;8:734.
7.
Benveniste H, Lee H, Volkow ND. The glymphatic pathway. Neuroscientist Epub 2017 Jan 1.
8.
Praetorius J. Water and solute secretion by the choroid plexus. Pflugers Arch 2007;454:1–18.
9.
Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain 2017;140:2691–2705.
10.
Weed LH. Studies on cerebro-spinal fluid. No. III: the pathways of escape from the subarachnoid spaces with particular reference to the arachnoid villi. J Med Res 1914;31:51–91.
11.
Iliff JJ, Goldman SA, Nedergaard M. Implications of the discovery of brain lymphatic pathways. Lancet Neurol 2015;14:977–979.
12.
Weller RO, Djuanda E, Yow HY, Carare RO. Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 2009;117:1–14.
13.
Weed LH. Studies on cerebro-spinal fluid. No. II: the theories of drainage of cerebro-spinal fluid with an analysis of the methods of investigation. J Med Res 1914;31:21–49.
14.
Murtha LA, Yang Q, Parsons MW, et al. Cerebrospinal fluid is drained primarily via the spinal canal and olfactory route in young and aged spontaneously hypertensive rats. Fluids Barriers CNS 2014;11:12.
15.
Mamourian AC, Towfighi J. MR of giant arachnoid granulation, a normal variant presenting as a mass within the dural venous sinus. AJNR Am J Neuroradiol 1995;16:901–904.
16.
Gailloud P, Muster M, Khaw N, et al. Anatomic relationship between arachnoid granulations in the transverse sinus and the termination of the vein of Labbé: an angiographic study. Neuroradiology 2001;43:139–143.
17.
Upton ML, Weller RO. The morphology of cerebrospinal fluid drainage pathways in human arachnoid granulations. J Neurosurg 1985;63:867–875.
18.
Lenck S, Vallée F, Labeyrie MA, et al. Stenting of the lateral sinus in idiopathic intracranial hypertension according to the type of stenosis. Neurosurgery 2017;80:393–400.
19.
Okudera T, Huang YP, Ohta T, et al. Development of posterior fossa dural sinuses, emissary veins, and jugular bulb: morphological and radiologic study. AJNR Am J Neuroradiol 1994;15:1871–1883.
20.
Lee H, Xie L, Yu M, et al. The effect of body posture on brain glymphatic transport. J Neurosci 2015;35:11034–11044.
21.
Roberts DR, Albrecht MH, Collins HR, et al. Effects of spaceflight on astronaut brain structure as indicated on MRI. N Engl J Med 2017;377:1746–1753.
22.
Lawley JS, Petersen LG, Howden EJ, et al. Effect of gravity and microgravity on intracranial pressure. J Physiol 2017;595:2115–2127.
23.
Reid AC, Matheson MS, Teasdale G. Volume of the ventricles in benign intracranial hypertension. Lancet 1980;2:7–8.
24.
Sørensen PS, Thomsen C, Gjerris F, Schmidt J, Kjaer L, Henriksen O. Increased brain water content in pseudotumour cerebri measured by magnetic resonance imaging of brain water self diffusion. Neurol Res 1989;11:160–164.
25.
Alperin N, Ranganathan S, Bagci AM, et al. MRI evidence of impaired CSF homeostasis in obesity-associated idiopathic intracranial hypertension. AJNR Am J Neuroradiol 2013;34:29–34.
26.
Bidot S, Saindane AM, Peragallo JH, Bruce BB, Newman NJ, Biousse V. Brain imaging in idiopathic intracranial hypertension. J Neuroophthalmol 2015;35:400–411.
27.
Maralani PJ, Hassanlou M, Torres C, et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol 2012;67:656–663.
28.
Perez MA, Bialer OY, Bruce BB, Newman NJ, Biousse V. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol 2013;33:330–337.
29.
Butros SR, Goncalves LF, Thompson D, Agarwal A, Lee HK. Imaging features of idiopathic intracranial hypertension, including a new finding: widening of the foramen ovale. Acta Radiol 2012;53:682–688.
30.
Bialer OY, Rueda MP, Bruce BB, Newman NJ, Biousse V, Saindane AM. Meningoceles in idiopathic intracranial hypertension. AJR Am J Roentgenol 2014;202:608–613.
31.
San Millan D, Kohler R. Enlarged CSF spaces in pseudotumor cerebri. AJR Am J Roentgenol 2014;203:W457–W458.
32.
Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003;60:1418–1424.
33.
Baryshnik DB, Farb RI. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 2004;62:1445–1446.
34.
Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg 2012;116:538–548.
35.
Abdelfatah MA. Normal pressure pseudotumor cerebri: a series of six patients. Turk Neurosurg 2017;27:208–211.
36.
Hartmann AJ, Soares BP, Bruce BB, et al. Imaging features of idiopathic intracranial hypertension in children. J Child Neurol 2017;32:120–126.
37.
Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment, and outcome. Am J Ophthalmol 1999;127:178–182.
38.
Bruce BB, Kedar S, Van Stavern GP, Corbett JJ, Newman NJ, Biousse V. Atypical idiopathic intracranial hypertension: normal BMI and older patients. Neurology 2010;74:1827–1832.
39.
Agre P, Sasaki S, Chrispeels MJ. Aquaporins: a family of water channel proteins. Am J Physiol 1993;265:F461.
40.
da Silva IV, Soveral G. Aquaporins in obesity. Adv Exp Med Biol 2017;969:227–238.
Letters to the Editor
30 October 2018
Author response to Kronenberg et al.
Stephanie Lenck, Interventional Neuroradiologist| Department of Neuroradiolgy, Groupe Hospitalier Pitié-Salpêtrière, Université Paris Sorbonne (Paris, France)
Patrick Nicholson, Interventional Neuroradiologist| Department of Medical Imaging, Toronto Western Hospital, University of Toronto (Toronto, Canada)

We thank Drs. Kronenberg and Kunte for their comments and interest in our Medical Hypothesis.1 Several authors have suggested that most patients with idiopathic CSF leaks have underlying idiopathic intracranial hypertension (IIH).2,3 Several clinical and radiologic arguments support this. First, there is the common clinical pattern in which the disease occurs (young obese women), then the high prevalence of radiologic signs of IIH in patients with idiopathic CSF leaks,4 the development of IIH symptoms following CSF leak repair, as well as the high rate of recurrence after surgery.5 We, therefore, suggest that the leaks are directly caused by overflow from the overburdened lymphatic CSF outflow pathway in these cases. The chronic excess of increased CSF pressure in the sheaths of the cranial nerves, and especially the olfactory bulbs, would lead to the progressive erosion of the bone and the dura matter at the level of the skull base (e.g., the cribriform plate), eventually resulting in CSF leaks. The leak will immediately relieve the headache and the IIH symptoms experienced by the patient, since it is a “natural” CSF diversion procedure. However, its surgical repair may result either in the development of IIH symptoms or in a recurrence of a leak. This recognition of this entity is important in clinical practice, when facing a patient with a CSF leak caused by IIH, since the treatment of the leak should be performed in conjunction with treatment of IIH, which is the often the underlying cause of the leak.

  1. Lenck S, Radovanovic I, Nicholson P, et al. Idiopathic intracranial hypertension: The veno glymphatic connections. Neurology 2018;91:515–522.
  2. Pérez MA, Bialer OY, Bruce BB, Newman NJ, Biousse V. Primary spontaneous cerebrospinal fluid leaks and idiopathic intracranial hypertension. J Neuroophthalmol 2013;33:330–337.
  3. Bialer OY, Rueda MP, Bruce BB, et al. Meningoceles in idiopathic intracranial hypertension. AJR Am J Roentgenol 2014;202:608–613.
  4. Martínez-Capoccioni G, Serramito-García R, Martín-Bailón M, García-Allut A, Martín-Martín C. Spontaneous cerebrospinal fluid leaks in the anterior skull base secondary to idiopathic intracranial hypertension. Eur Arch Otorhinolaryngol 2017;274:2175–2181.
  5. Teachey W, Grayson J, Cho DY, Riley KO, Woodworth BA. Intervention for elevated intracranial pressure improves success rate after repair of spontaneous cerebrospinal fluid leaks. Laryngoscope 2017;127:2011–2016.

For disclosures, please contact the editorial office at [email protected].

14 October 2018
Author response to De Simone et al.
Stephanie Lenck, Interventional Neuroradiologist| Department of Neuroradiolgy, Groupe Hospitalier Pitié-Salpêtrière, Université Paris Sorbonne (Paris, France)
Patrick Nicholson, Interventional Neuroradiologist| Department of Medical Imaging, Toronto Western Hospital, University of Toronto (Toronto, Canada)

We thank Drs. De Simone and Ranieri for their comments and interest in our paper.1

Our hypothesis doesn't support a dysfunction of aquaporin 4 (AQP-4) in idiopathic intracranial hypertension (IIH); rather, an unknown type of AQP (e.g., aquaglyceroporin) may be involved at the venodural junction and may trigger the hydrodynamic cascade of IIH. We agree that a direct discharge of glymphatic fluid into the venous blood has not been documented in studies of CSF hydrodynamics;2 however, the techniques used to demonstrate the existence of the glymphatic and lymphatic systems of the brain were not able to detect any venous CSF outflow, leading some to question even the existence of a venous CSF outflow pathway in the brain.3 Based on our clinical experience (i.e., cerebral venous thrombosis) and on previous experimental studies, we feel that a direct discharge of glymphatic fluid into venous blood seems highly likely.4

It may seem hazardous to extrapolate the physiology of CSF excretion from animals to humans, since the venous physiology and anatomy of quadrupedal animals are very different from those of bipedal humans.5 We agree that the discovery of an arachnoid granulation (AG) may be incidental and that the prevalence of AG in the lumen of the sinuses increase with age; however, pathologic and radiologic studies have described a specific type of AG, mostly observed in the transverse sinus and particularly at the junction between the vein of Labbé and the transverse sinus (e.g., lateral sinus stenoses in IIH). These granulations are centered on a vein and associated with the point of entry of a cortical vein into the dural sinus. We named them "vascular AGs" to differentiate from avascular granulations which allow the pressure-dependant transport of CSF from the subarachnoid space to the venous blood of the dural sinuses. These vascular AGs may allow a connection between the perivascular spaces of large cortical veins to the venous blood of the dural sinuses and may be involved in the discharge of interstitial fluid (CSF) from the glymphatic system to the venous blood of the dural vessels.6

Several arguments support the hypothesis that extrinsic stenoses are caused by the compression of the lateral sinus by the congested brain and CSF (and not by the increased intracranial pressure [ICP]), including the radiologic aspect of such stenoses on MRI, the propensity of such stenoses to reoccur outside the stented portion of the sinus, the fact that the radial force of the stent is usually enough to reopen the sinus with no need for balloon angioplasty, and their disappearance after CSF removal.7,8 We agree that the venous sinus stenosis is the main precipitating factor in IIH symptoms since it makes the venous outflow pathway ineffective for the glymphatic reabsorption and the direct reabsorption, which aims to balance the ICP. Stent placement allows reestablishment of the direct reabsorption of the CSF from the subarachnoid space to the venous blood of the dural sinuses, thus regulating the ICP and resolving IIH symptoms.

  1. Lenck S, Radovanovic I, Nicholson P, et al. Idiopathic intracranial hypertension: The veno glymphatic connections. Neurology 2018;91:515–522.
  2. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 2012;4:147ra111.
  3. Murtha LA, Yang Q, Parsons MW, et al. Cerebrospinal fluid is drained primarily via the spinal canal and olfactory route in young and aged spontaneously hypertensive rats. Fluids Barriers CNS 2014;11:12.
  4. Boulton M, Young A, Hay J, et al. Drainage of CSF through lymphatic pathways and arachnoid villi in sheep: measurement of 125I-albumin clearance. Neuropathol Appl Neurobiol 1996;22:325–333.
  5. Aurboonyawat T, Suthipongchai S, Pereira V, Ozanne A, Lasjaunias P. Patterns of cranial venous system from the comparative anatomy in vertebrates. Part I, introduction and the dorsal venous system. Interv Neuroradiol 2007;13:335–344.
  6. Trimble CR, Harnsberger HR, Castillo M, Brant-Zawadzki M, Osborn AG. "Giant" arachnoid granulations just like CSF?: NOT!! AJNR Am J Neuroradiol 2010;31:1724–1728.
  7. Baryshnik DB, Farb RI. Changes in the appearance of venous sinuses after treatment of disordered intracranial pressure. Neurology 2004;62:1445–1446.
  8. Lenck S, Vallée F, Labeyrie MA, et al. Stenting of the Lateral Sinus in Idiopathic Intracranial Hypertension According to the Type of Stenosis. Neurosurgery 2017;80:393–400.

For disclosures, please contact the editorial office at [email protected].

7 October 2018
Reader response: Idiopathic intracranial hypertension: The veno glymphatic connections
Golo Kronenberg, Psychiatrist| College of Life Sciences - University of Leicester / Leicestershire Partnership NHS Trust (Leicester, England)
Hagen Kunte, Neurologist and Psychiatrist| MSB-Medical School Berlin (Berlin, Germany)

The Medical Hypothesis paper by Lenck et al.1 provided an exciting new angle on recent findings concerning CSF circulation in the brain. The authors succinctly summarized clinical and radiologic evidence supporting their hypothesis that dysfunction of veno glymphatic connections lies at the heart of idiopathic intracranial hypertension (IIH). In particular, the authors speculated that chronic overflow of CSF in the sheaths of the olfactory bulbs may result in CSF rhinorrhea by eroding the cribriform plate.1 Olfactory dysfunction, especially a marked impairment in olfactory threshold levels, is an even more common yet under-recognized presentation of IIH.2,3 Indeed, as early as 2008, Dr. Kapoor speculated that dysfunction of the extensive lymphatic network around the olfactory nerves might be causally linked to IIH, making hyposmia a more sensitive predictor of IIH than other clinical features.4

  1. Lenck S, Radovanovic I, Nicholson P, et al. Idiopathic intracranial hypertension: The veno glymphatic connections. Neurology 2018;91:515–522.
  2. Kunte H, Schmidt F, Kronenberg G, et al. Olfactory dysfunction in patients with idiopathic intracranial hypertension. Neurology 2013;81:379–382.
  3. Bershad EM, Urfy MZ, Calvillo E, et al. Marked olfactory impairment in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2014;85:959–964.
  4. Kapoor KG. Do patients with idiopathic intracranial hypertension suffer from hyposmia? Med Hypotheses 2008;71:816–817.

For disclosures, please contact the editorial office at [email protected].

1 October 2018
Reader response: Idiopathic intracranial hypertension: The veno glymphatic connections
Roberto De Simone, Neurologist| Headache Centre, Reproductive Sciences and Odontostomatology, University of Naples Federico II (Naples, Italy)
Angelo Ranieri, Neurologist| Division of Neurology and Stroke Unit, Hospital Antonio Cardarelli (Naples, Italy)

We read the interesting idiopathic intracranial hypertension (IIH) pathogenetic Medical Hypothesis by Lenck et al.1 We agree that the lymphatic interstitial/cerebrospinal fluid (ISF/CSF) outflow is increased by intracranial hypertension and may explain part of IIH symptoms. However, the asymptomatic primary impairment of ISF/CSF outflow proposed by the authors—mediated by a putative acquaporine 4 (AQP4) dysfunction at the vascular arachnoid granulations (VAG) interface with the dural sinuses and followed by the secondary sinus stenosis with symptomatic shift—is exceedingly weak and possibly misleading. In fact, the AQP4-glymphatic existence as a convective vs diffusive ISF/CSF outflow route has been very recently questioned.2 ISF/CSF containing intraventricular administered tracers do not drain through venous sinus, as proposed, but through nasal lymphatic.3 The VAG are very common in subjects without intracranial vascular pathology,4 while IIH is rare. The sinus wall should bear CSF pressure much higher than that possibly associated with an asymptomatic stage of lymphatic dysfunction.5 Finally, after sinus stenting, the intracranial pressure returns to fully physiologic values in responders.6 Therefore, the hypothesis of an asymptomatic primary CSF hypertension by glymphatic impairment leading to a secondary symptomatic sinus stenosis is highly unlikely.

  1. Lenck S, Radovanovic I, Nicholson P, et al. Idiopathic intracranial hypertension: The veno glymphatic connections. Neurology 2018;91:515-522.
  2. Abbott NJ, Pizzo ME, Preston JE, et al. The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system? Acta Neuropathol 2018;135:387-407.
  3. Murtha LA, Yang Q, Parsons MW, et al. Cerebrospinal fluid is drained primarily via the spinal canal and olfactory route in young and aged spontaneously hypertensive rats. Fluids Barriers CNS 2014;11:12.
  4. Gailloud P, Muster M, Khaw N, et al. Anatomic relationship between arachnoid granulations in the transverse sinus and the termination of the vein of Labbe: an angiographic study. Neuroradiology 2001;43:139-143.
  5. Martins AN, Kobrine AI, Larsen DF. Pressure in the sagittal sinus during intracranial hypertension in man. J Neurosurg 1974;40:603-608.
  6. Patsalides A, Oliveira C, Wilcox J, et al. Venous sinus stenting lowers the intracranial pressure in patients with idiopathic intracranial hypertension. J NeuroInterv Surg Epub 2018 Jun 5.

For disclosures, please contact the editorial office at [email protected].

Information & Authors

Information

Published In

Neurology®
Volume 91Number 11September 11, 2018
Pages: 515-522
PubMed: 30201744

Publication History

Received: January 26, 2018
Accepted: June 7, 2018
Published online: September 10, 2018
Published in print: September 11, 2018

Permissions

Request permissions for this article.

Disclosure

S. Lenck received 3 grants from Assistance Publique Hôpitaux de Paris (Bourse de Mobilité APHP, Paris, France); Medtronic Inc., and MicroVention Inc. I. Radovanovic, P. Nicholson, M. Hodaie, T. Krings, and V. Mendes-Pereira report no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.

Study Funding

No targeted funding reported.

Authors

Affiliations & Disclosures

Stéphanie Lenck, MD
From the Division of Neuroradiology (S.L., P.N., M.H., T.K., V.M.-P.), Department of Medical Imaging, Toronto Western Hospital, University Health Network, Canada; Division of Neuroradiology (S.L.), Groupe Hospitalier Pitié Salpêtrière–Université Paris Sorbonne, France; Division of Neurosurgery (I.R., M.H., V.M.-P.), Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto; and Krembil Neuroscience Center (I.R.), University Health Network, Toronto, Canada.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
(1) Research grant from Medtronic Inc.; (2) Research grant from Microvention Europe Inc.
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
(1) Research grant from Assistance Publique H?pitaux de Paris, Paris, France. Bourse de Mobilit? APHP.
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Ivan Radovanovic, MD, PhD
From the Division of Neuroradiology (S.L., P.N., M.H., T.K., V.M.-P.), Department of Medical Imaging, Toronto Western Hospital, University Health Network, Canada; Division of Neuroradiology (S.L.), Groupe Hospitalier Pitié Salpêtrière–Université Paris Sorbonne, France; Division of Neurosurgery (I.R., M.H., V.M.-P.), Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto; and Krembil Neuroscience Center (I.R.), University Health Network, Toronto, Canada.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
Start up funding from University Health Network and University of Toronto support my research
Research Support, Foundations and Societies:
1.
Brain Aneurysm Foundation
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Patrick Nicholson, MD
From the Division of Neuroradiology (S.L., P.N., M.H., T.K., V.M.-P.), Department of Medical Imaging, Toronto Western Hospital, University Health Network, Canada; Division of Neuroradiology (S.L.), Groupe Hospitalier Pitié Salpêtrière–Université Paris Sorbonne, France; Division of Neurosurgery (I.R., M.H., V.M.-P.), Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto; and Krembil Neuroscience Center (I.R.), University Health Network, Toronto, Canada.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Mojgan Hodaie, MD
From the Division of Neuroradiology (S.L., P.N., M.H., T.K., V.M.-P.), Department of Medical Imaging, Toronto Western Hospital, University Health Network, Canada; Division of Neuroradiology (S.L.), Groupe Hospitalier Pitié Salpêtrière–Université Paris Sorbonne, France; Division of Neurosurgery (I.R., M.H., V.M.-P.), Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto; and Krembil Neuroscience Center (I.R.), University Health Network, Toronto, Canada.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
speaker honorarium, Medtronic(C)
Editorial Boards:
1.
Academic Editor, PLoS ONE Editorial Board, Stereotactic and Functional Neurosurgery Editorial Board, Journal of Neurosurgery
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
Previous research funding by Medtronic Research funding by ELEKTA
Clinical Procedures or Imaging Studies:
1.
Surgery for idiopathic intracranial hypertension
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
Grants from CIHR
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Timo Krings, MD, PhD
From the Division of Neuroradiology (S.L., P.N., M.H., T.K., V.M.-P.), Department of Medical Imaging, Toronto Western Hospital, University Health Network, Canada; Division of Neuroradiology (S.L.), Groupe Hospitalier Pitié Salpêtrière–Université Paris Sorbonne, France; Division of Neurosurgery (I.R., M.H., V.M.-P.), Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto; and Krembil Neuroscience Center (I.R.), University Health Network, Toronto, Canada.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
(1) Interventional Neuroradiology, Deputy Chief Editor, 5 years (2) Clinical Neuroradiology, Editor, 8 years (3) AJNR, Associate Editor, 3 years
Patents:
1.
NONE
Publishing Royalties:
1.
Case-based Interventional Neuroradiology, Thieme, 2011 Case-based Neurovascular Anatomy, Thieme 2013
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Consultant for Stryker and for Medtronic (Covidien)
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Vitor Mendes-Pereira, MD
From the Division of Neuroradiology (S.L., P.N., M.H., T.K., V.M.-P.), Department of Medical Imaging, Toronto Western Hospital, University Health Network, Canada; Division of Neuroradiology (S.L.), Groupe Hospitalier Pitié Salpêtrière–Université Paris Sorbonne, France; Division of Neurosurgery (I.R., M.H., V.M.-P.), Department of Surgery, Toronto Western Hospital, University Health Network, University of Toronto; and Krembil Neuroscience Center (I.R.), University Health Network, Toronto, Canada.
Disclosure
Scientific Advisory Boards:
1.
NONE
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
NONE
Editorial Boards:
1.
European Journal of Radiology. Associate Editor, from 2014-current
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
NONE
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Lenck [email protected]
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

Author Contributions

Dr. Stéphanie Lenck: study concept and design, analysis and interpretation, study supervision. Dr. Ivan Radovanovic: study concept and design, analysis and interpretation, critical revision of the manuscript for important intellectual content, study supervision. Dr. Patrick Nicholson: analysis and interpretation, critical revision of the manuscript for important intellectual content. Dr. Mojgan Hodaie: analysis and interpretation, critical revision of the manuscript for important intellectual content. Dr. Timo Krings: analysis and interpretation, critical revision of the manuscript for important intellectual content. Dr. Vitor Mendes-Pereira: study concept and design, analysis and interpretation, critical revision of the manuscript for important intellectual content, study supervision.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Diffusion-Weighted Imaging Reveals Impaired Glymphatic Clearance in Idiopathic Intracranial Hypertension, American Journal of Neuroradiology, 45, 2, (149-154), (2024).https://doi.org/10.3174/ajnr.A8088
    Crossref
  2. Association of Extent of Transverse Sinus Stenosis With Cerebral Glymphatic Clearance in Patients With Idiopathic Intracranial Hypertension, Neurology, 103, 1, (2024)./doi/10.1212/WNL.0000000000209529
    Abstract
  3. Regulation of brain fluid volumes and pressures: basic principles, intracranial hypertension, ventriculomegaly and hydrocephalus, Fluids and Barriers of the CNS, 21, 1, (2024).https://doi.org/10.1186/s12987-024-00532-w
    Crossref
  4. Hemolacria due to possible idiopathic intracranial hypertension: A case report, Cephalalgia Reports, 7, (2024).https://doi.org/10.1177/25158163241267322
    Crossref
  5. Jugular venous narrowing and spontaneous spinal cerebrospinal fluid leaks: A case–control study exploring association and proposed mechanism, Interventional Neuroradiology, 30, 6, (812-818), (2024).https://doi.org/10.1177/15910199241287417
    Crossref
  6. Idiopathic intracranial hypertension pathogenesis: The jugular hypothesis, Interventional Neuroradiology, (2024).https://doi.org/10.1177/15910199241270660
    Crossref
  7. The correlation between intracranial pressure and venous sinus pressures changes after venous sinus stenting, Journal of NeuroInterventional Surgery, (jnis-2024-022250), (2024).https://doi.org/10.1136/jnis-2024-022250
    Crossref
  8. Total brain volume is associated with severity of transverse sinus stenosis in idiopathic intracranial hypertension, Journal of NeuroInterventional Surgery, (jnis-2024-021938), (2024).https://doi.org/10.1136/jnis-2024-021938
    Crossref
  9. Progress and recognition of idiopathic intracranial hypertension: A narrative review, CNS Neuroscience & Therapeutics, 30, 8, (2024).https://doi.org/10.1111/cns.14895
    Crossref
  10. Pseudotumor cerebri in the paediatric population: clinical features, treatment and prognosis, Neurología (English Edition), 39, 2, (105-116), (2024).https://doi.org/10.1016/j.nrleng.2024.01.004
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share